Skip to main content
SpringerLink
Log in

Bivalirudin: immediate infusion needed to ensure optimal dosing

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Deliargyris EN. Direct Healthcare Professional Communication on approved dosing regimens for Angiox (biavlirudin) for PCI, following reports of inappropriate use. Internet Document : [3 pages], 7 Jan 2013. Available from: URL: http://www.imb.ie

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bivalirudin: immediate infusion needed to ensure optimal dosing. Reactions Weekly 1436, 3 (2013). https://doi.org/10.1007/s40278-013-0857-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-0857-3

Search

Navigation